Kachó Degenerashon di Sistema Múltiple di Kachó den Kerry Blue Terrier (CMSD-KBT)

The Canine Multiple System Degeneration (CMSD) DNA test is essential for Kerry Blue Terrier owners to ensure their dogs' health. CMSD is a hereditary neurological disorder affecting coordination and movement in Kerry Blue Terriers. Early genetic testing helps identify carriers and affected dogs, enabling responsible breeding decisions. By using the CMSD DNA test, breeders can reduce the risk of passing this debilitating condition to future generations. This test provides accurate, reliable results, promoting the well-being of your Kerry Blue Terrier. Protect your dog’s health with the CMSD DNA test today. Regular screening supports a healthier, happier canine companion.

Abreviashon : CMSD-KBT

Mutashon analisá : SERAC1 c.1536G>A

Herensha : Autosomal Resesivo

Sigla

CMSD-KBT

Frekuensha opservá

Poko komun

Severidat klíniko

Grave

Klasifikashon klíniko

Malesanan Neurológiko

Mutashon analisá

SERAC1 c.1536G>A
p.(Trp512*)

Modo di herensia

Autosomal Resesivo

Resumen di prueba:

Canine Multiple System Degeneration (CMSD) is a genetic disorder affecting Kerry Blue Terriers, causing progressive neurological decline. A DNA test is available to identify carriers and affected dogs, helping breeders make informed decisions. Early detection through testing can prevent the spread of this debilitating condition within the breed. Responsible breeding practices rely on these genetic insights to maintain healthy Kerry Blue Terrier populations. Overall, the CMSD DNA test is a valuable tool for canine health management.

Obtenibel for di e pakete : Basic

E tèst di DNA aki ta inkluí kuminsando for di nos pakete Basic — i tambe ta parti di e paketenan Basic, Standard, Advanced, Complete.

Wak e paketenan di tèst di DNA →

Skohe e pakete ku ta pas mihó ku bo strategia di krio òf salú di bo bestianan.

Understanding Canine Multiple System Degeneration in Kerry Blue Terriers (CMSD-KBT)

Canine Multiple System Degeneration (CMSD) is a progressive neurological disorder that primarily affects Kerry Blue Terriers. This condition is characterized by the degeneration of multiple systems within the nervous system, leading to a range of debilitating symptoms that can significantly impact the quality of life of affected dogs.

Symptoms of CMSD-KBT

The symptoms of CMSD-KBT typically manifest in early to mid-adulthood, although the age of onset can vary. Common signs include balance problems, difficulty walking, and a general lack of coordination. As the disease progresses, affected dogs may exhibit muscle weakness, tremors, and a decline in overall mobility. In some cases, dogs may also experience changes in behavior, such as increased anxiety or a reluctance to engage in normal activities.

Pathophysiology of CMSD-KBT

The underlying cause of CMSD-KBT lies in genetic mutations that affect the nervous system's ability to function properly. These mutations lead to the degeneration of nerve cells, which in turn causes a breakdown of communication between the brain and the body. This disruption results in the clinical symptoms observed in affected dogs. Understanding the genetic basis of CMSD-KBT is crucial for breeders and owners, as it allows for informed decisions regarding breeding practices and the management of affected animals.

Maneho i Kuido pa Kachó Afektá

While there is currently no cure for CMSD-KBT, management strategies can help improve the quality of life for affected dogs. Regular veterinary check-ups are essential for monitoring the progression of the disease and addressing any health concerns that arise. Physical therapy and rehabilitation exercises can assist in maintaining mobility and strength. Additionally, providing a safe and supportive environment can help dogs cope with their symptoms and enhance their overall well-being.

Konklushon

Canine Multiple System Degeneration in Kerry Blue Terriers is a serious condition that requires attention from dog owners and breeders. By understanding the symptoms, underlying causes, and management strategies associated with CMSD-KBT, stakeholders can work towards improving the lives of affected dogs while making informed breeding decisions to reduce the prevalence of this condition in the breed.

Rasa rekonosé pa e tèst: Degenerashon di Sistema Múltiple di Kachó den Kerry Blue Terrier (CMSD-KBT)

Kerry Blue Terrier

Interpretashon di genotiponan Genotipo Estado Siña mas tokante e interpretashon di genotipo FAQ: komprondementu di e interpretashon di resultado Kiko “Kla” ta nifiká? E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pas’é pa otro hende. Un “Transportadó” ta serio? No. E animal ta generalmente salú pero por transmití e mutashon na su yunan. Kiko si un bestia ta “Afektá”? E ta karga dos kopia mutá. Ta spera señalnan klíniko dependiendo di e malesa. E no mester wòrdu kriá. Dikon tin diferensia entre hòmber/muhé? Algun malesa ta ligá na sekso, pues nan ekspreshon ta varia dependiendo di e sekso di e animal. E animal tin dos kopia normal di e gene. No tin riesgo di desaroyá òf transmití e malesa. Portadó heterozigoto: un kopia mutá. E animal por lo general no ta wòrdu afektá klínikamente pero por pasa e mutashon pa e yunan. Portadó maskulino òf afektá dependiendo di e moda di herensia. Maskulino tin solamente un kromosoma X òf Y. Portadó femenino heterozigoto: un kopia mutá. E por pasa e mutashon i tin bia por mustra señalnan klíniko leve dependiendo di e kondishon. Dos kopia mutá di e gene. E animal ta kore riesgo di desaroyá e kondishon asosiá.

🧬 Interpretation of genotypes CMSD-KBT

Genotipo

Estado

🟡 N/N

No-transportador - Sin Riesgo

🟡 N/CMSD-KBT

Transportadó - Sin Riesgo

❌ CMSD-KBT/CMSD-KBT

Afektá - Na Riesgo

FAQ: komprondementu di e interpretashon

Kiko “Kla” ta nifiká?

E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.

Un “Transportadó” ta serio?

No. E animal ta generalmente salú pero por transmití e mutashon na su yu.

Kiko si un bestia ta “Afektá”?

E ta karga dos kopia mutá. Ta spera señalnan klíniko dependiendo di e malesa. E no mester wòrdu kriá.

Dikon tin diferensia entre hòmber/muhé?

Algun malesa ta mará na sekso, pues nan ekspreshon ta varia dependiendo di e sekso di bestia.

Pronóstiko di Genotipo pa Desendientenan Mama Tata no-transportador Transportador Afektá Krus faborabel: mayoria Riesgo di transportadó ta predominante. Mayoria afektá Filter pa genotipo di mama Filter pa genotipo di tata Tur Pronostiká Desendiente E animal tin dos kopia normal di e gene. No tin riesgo di desaroyá òf transmití e malesa. Portadó heterozigoto: un kopia mutá. E animal por lo general no ta wòrdu afektá klínikamente pero por pasa e mutashon pa e yunan. Portadó maskulino òf afektá dependiendo di e moda di herensia. Maskulino tin solamente un kromosoma X òf Y. Portadó femenino heterozigoto: un kopia mutá. E por pasa e mutashon i tin bia por mustra señalnan klíniko leve dependiendo di e kondishon. Dos kopia mutá di e gene. E animal ta kore riesgo di desaroyá e kondishon asosiá.

Pronostiká Desendiente

Filter pa genotipo di mama Filter pa genotipo di tata

N/N (no-transportador) )

N/CMSD-KBT (Transportador) )

CMSD-KBT/CMSD-KBT (Afektá) )

FAQ di Prueba di DNA

Kiko e tèst di DNA aki ta detektá?

This DNA test detects the mutation associated with Canine Multiple System Degeneration In Kerry Blue Terrier (CMSD-KBT) in order to identify clear, carrier, or at-risk animals.

Dikon tèst un bestia di krio?

Prueba di DNA ta yuda kriadónan plania parehamentu mas sigur i redusí e riesgo di transmití e mutashon na yunan.

Kiko ta e moda di herensia di e tèst aki?

E moda di herensia raportá pa e tèst aki ta Outosomal Resesivo.

Kua mutashon ta wòrdu analisá den e tèst aki?

This test analyses the mutation SERAC1 c.1536G>A.

Un bestia kargadó ta nesesariamente afektá?

No nesesariamente. Interpretashon ta dependé di e patronchi di herensia i e genotipo resultante.

Referensianan

Johnson GS, Mhlanga-Mutangadura T, Morava E, Kozicz T, Taylor JF, O’Brien DP, Schnabel RD. Canine Multiple System Degeneration is Associated with Distinct SERAC1 Mutations in Two Different Dog Breeds [abstract]. Presented at the 63rd Annual Meeting of the American Society of Human Genetics in Boston, Massachusetts; 2013 Oct 22-26.

Mi Portal di DNA